Position: Associate Director, Strategic Accounts
Location: Michigan Region
Transforming Cancer Therapy Together
Transforming what patients can expect from cancer therapy takes passion and a strong dedicated team. When you join ADC Therapeutics, you will join a group of talented people who share this mission.
Why ADC Therapeutics?
ADC Therapeutics (NYSE): is a commercial, global leader and pioneer in the field of antibodydrug conjugates (ADCs) with specialized capabilities from clinical through commercialization. Our CD19directed ADC for relapsedrefractory nonHodgkin lymphoma, ZYNLONTA® (loncastuxamab tesirine lpyl) has received accelerated approval in the United States and conditional approval from the European Commission. ZYNLONTA is also being evaluated in combination with other anticancer therapeutics and in earlier lines of therapy to determine if it has potential to treat an even broader range of patients. In addition to ZYNLONTA, ADC Therapeutics has a PSMAtargeting ADC in ongoing development.
We are a team of approximately 200 patientfocused, purposedriven employees with a shared mission to transform the treatment paradigm for patients. If you’re interested in making a difference in the lives of patients worldwide with a team of likeminded colleagues, operating in a flexible work environment, come join us on our journey!
To learn more about ADC Therapeutics, our values, and our exceptional culture, please visit us at https:adctherapeutics.com and LinkedIn.
Job responsibilities may include, but are not limited to:
• Meet or exceed business objectives within our compliance framework
• Full people management responsibilities for their team of Hematology Therapeutic Specialists
• Develop an understanding of accounts and perceptionsentiment towards ZYNLONTA
• Utilize approved materials and resources to drive awareness and advocacy for ZYNLONTA
• Participate in account reviews and business reviews with the crossfunctional ADCT team
Dentsu Media
iProspect
dentsu B2B
Recorded Future
Broadcom Inc.